Nonfunctioning pituitary adenomas: The Oxford experience

Nature Reviews Endocrinology

Volumn 5, Issue 9, 2009, Pages 519-522

  Wass, John A H ^a   Karavitaki, Niki ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CORTICOTROPIN; DOPAMINE RECEPTOR STIMULATING AGENT; PROLACTIN;

CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; DIAGNOSTIC ACCURACY; HUMAN; IMMUNOHISTOCHEMISTRY; NONFUNCTIONING PITUITARY ADENOMA; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA; TUMOR VOLUME;

ADENOMA; HUMANS; PITUITARY NEOPLASMS; PROLACTIN;

EID: 70349319858     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2009.147     Document Type: Note

References (20)

1. Ezzat, S. et al. The prevalence of pituitary adenomas: a systematic review. Cancer 101, 613-619 (2004).
2. Davis, J. R. et al. Pituitary tumours. Reproduction 121, 363-371 (2001).
3. Nilsson, B., Gustavsson-Kadaka, E., Bengtsson, B.-A. & Jonsson, B. Pituitary adenomas in sweden between 1958 and 1991: incidence, survival, and mortality. J. Clin. Endocrinol. Metab. 85, 1420-1425 (2000).
4. Daly, A. F. et al. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J. Clin. Endocrinol. Metab. 91, 4769-4775 (2006).
5. Fernandez, A. et al. High prevalence of pituitary adenomas: a community-based study in the city of Banbury. Presented at the British endocrine society meeting (2008).
6. Karavitaki, N. et al. Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition A study of 226 patients with histologically verified non-functioning pituitary macroadenoma. Clin. Endocrinol. (Oxf.) 65, 524-529 (2006).
7. Reincke, M. et al. The ?incidentaloma? of the pituitary gland. Is neurosurgery required JAMA 263, 2772-2776 (1990).
8. Dekkers, O. M. et al. Observation alone after transsphenoidal surgery for nonfunctioning pituitary macroadenoma. J. Clin. Endocrinol. Metab. 91, 1796-1801 (2006).
9. Karavitaki, N. et al. What is the natural history of nonoperated nonfunctioning pituitary adenomas Clin. Endocrinol. (Oxf.) 67, 938-943 (2007).
10. Gittoes, N. et al. Radiotherapy for non-functioning pituitary tumours. Clin. Endocrinol. (Oxf.) 48, 331-337 (1998).
11. Brada, M. et al. Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma. BMJ 304, 1343-1346 (1992).
12. Turner, H. E., Stratton, I. M., Byrne, J. V. , Adams, C. B. & Wass, J. H. Audit of selected patients with nonfunctioning pituitary adenomas treated without irradiation a follow-up study. Clin. Endocrinol. (Oxf.) 51, 281-284 (1999).
13. Allen, K. & Wass, J. A. H. Prolonged postoperative follow-up is necessary for unirradiated non-functioning pituitary adenomata. Presented at the european congress of endocrinology (2006).
14. Bradley, K. J., Wass, J. A. & turner, H. E. Non-functioning pituitary adenomas with positive immunoreactivity for ActH behave more aggressively than ActH immunonegative tumours but do not recur more frequently. Clin. Endocrinol. (Oxf.) 58, 59-64 (2003).
15. Renner, U. et al. Heterogeneous dopamine D2 receptor subtype messenger ribonucleic acid expression in clinically nonfunctioning pituitary adenomas. J. Clin. Endocrinol. Metab. 83, 1368-1375 (1998).
16. Pivonello, R. et al. Dopamine receptor expression and function in clinically nonfunctioning pituitary tumors: comparison with the effectiveness of cabergoline treatment. J. Clin. Endocrinol. Metab. 89, 1674-1683 (2004).
17. Greenman, Y. et al. Postoperative treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists decreases tumour remnant growth. Clin. Endocrinol. (Oxf.) 63, 39-44 (2005).
18. Saveanu, A. & Jaquet, P. Somatostatin-dopamine ligands in the treatment of pituitary adenomas. Rev. Endocr. Metab. Disord. 10, 83-90 (2009).
19. Colao, A. M. et al. Medical therapy of pituitary adenomas: effects on tumor shrinkage. Rev. Endocr. Metab. Disord. 10, 111-123 (2009).
20. Colao, A. M. Medical therapy for clinically non-functioning pituitary adenomas. Endocr. Relat. Cancer 15, 905-915 (2008).